Clinical study of Moxifloxacin injection in treatment of bacterial infections of respiratory tract
LI Yong-f
Abstract
LI Yong-f
Abstract
Objective To evaluate the efficacy and safety of moxifloxacin injection in the treatment of respiratory tract bacterial infections.Methods A total of 60 patients were randomly divided into treatment group and control group(30 in each).The treatment group was treated with moxifloxacin injection,the control group was treated with levofloxacin injection both groups were treated for 7~14d.Results The total clinical effective rate was 93.3%in treatment group and 76.7% in control group(P0.05).The bacterial eradication rate in treatment group and in control group were 92.0% and 80.8% respectively(P0.05).There was significant difference between two group in the clinical efficacy.The incidence rate of adverse reactions was 13.3% in the treatment group and 16.7% in the control group(P0.05).Conclusion Moxifloxacin injection is an effective and safe antibiotics for the treatment of respiratory tract bacterial infections.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the efficacy and safety of moxifloxacin injection in the treatment of respiratory tract bacterial infections.Methods A total of 60 patients were randomly divided into treatment group and control group(30 in each).The treatment group was treated with moxifloxacin injection,the control group was treated with levofloxacin injection both groups were treated for 7~14d.Results The total clinical effective rate was 93.3%in treatment group and 76.7% in control group(P0.05).The bacterial eradication rate in treatment group and in control group were 92.0% and 80.8% respectively(P0.05).There was significant difference between two group in the clinical efficacy.The incidence rate of adverse reactions was 13.3% in the treatment group and 16.7% in the control group(P0.05).Conclusion Moxifloxacin injection is an effective and safe antibiotics for the treatment of respiratory tract bacterial infections.
Key concepts: Medicine, Levofloxacin, Moxifloxacin, Respiratory tract infections, Antibiotics, Respiratory tract, Adverse effect, Incidence (geometry)